ASLAN-003
As of the edition of 20 October 2026, ASLAN-003 is a small molecule: in active development; acts on DHODH.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Active, 2018
- Kind
- Small molecule
- Registered trials
- 4, 0 stopped early
- Disease areas
- Blood and lymph; Cancer; Skin and connective tissue
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| DHODH | Dihydroorotate dehydrogenase | Q02127 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 2 | 2 | 1 | 0 | 0 |
| All trials | 4 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| ASLAN Pharmaceuticals | Lead sponsor of trials | 2013 to now |